PTC Therapeutics (United States)
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for PTC Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
46%
Total
Publications
417
Total Open
Publications
190
Total
Citations
13K
Open Access
Percentage
46%
Total
Publications
417
Total Open
Publications
190
Total
Citations
13K
Breakdown
Publisher Open
13%
Both
23%
Other Platform Open
8%
Closed
56%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 44%
63
Hybrid 28%
40
No Guarantees 28%
41
Other Platform Open
Domain 79%
106
Other Internet 19%
26
Institution 11%
15
Preprint 7%
10
Public 3%
4
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 107 |
DOI | Other Internet | 26 |
bioRxiv | Preprint | 7 |
Europe PMC | Domain | 6 |
University of Melbourne | Institution | 4 |
Figshare | Public | 4 |
Research Square | Preprint | 3 |
Washington University in St. Louis | Institution | 2 |
University of Pisa | Institution | 2 |
University of Milan | Institution | 2 |